Clinical characteristics and prognostic factors in patients with stool cytomegalovirus positivity
Stool and plasma CMV VLs, antiviral treatment duration, and host factors such as immune status may influence outcomes in patients with intestinal CMV reactivation. Larger studies are needed to validate optimal VL thresholds for risk stratification.
Authors
- Ching-Hao Hsu (ORCID: https://orcid.org/0000-0001-7917-9434)
- Cheng‐Yu Chen (ORCID: https://orcid.org/0000-0003-0428-4373)
- Yu‐Jiun Chan (ORCID: https://orcid.org/0000-0001-8065-7421)
- Yi-Tien Hsuan
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Taipei Veterans General Hospital (TW)
- Ministry of Health and Welfare (TW)
- Chest Hospital, Ministry of Health and Welfare (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1097/jcma.0000000000001300
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00